Table 2.
Treatment-related adverse events. LVEF: left ventricle ejection fraction. HTA: hypertension
| Adverse events | Grade I | Grade II | Grade III | Grade IV | ||||
|---|---|---|---|---|---|---|---|---|
| n | % | n | % | n | % | n | % | |
| LVEF reduction | 0 | 0 | 2 | 4.4 | 0 | 0 | 0 | 0 |
| HTA | 1 | 2.2 | 1 | 2.2 | 0 | 0 | 0 | 0 |
| Heart failure | 0 | 0 | 0 | 0 | 1 | 2.2 | 0 | 0 |
| Hand–foot syndrome | 5 | 11.1 | 0 | 0 | 1 | 2.2 | 0 | 0 |
| Fatigue | 13 | 28.9 | 13 | 28.9 | 6 | 13.3 | 1 | 2.2 |
| Diarrhoea | 4 | 8.9 | 8 | 17.8 | 11 | 24.4 | 1 | 2.2 |
| Nausea | 4 | 8.9 | 8 | 17.8 | 8 | 17.8 | 1 | 2.2 |
| Vomiting | 8 | 17.8 | 3 | 6.7 | 6 | 13.3 | 0 | 0 |
| Mucositis | 2 | 4.4 | 3 | 6.7 | 1 | 2.2 | 0 | 0 |
| Hyporexia | 4 | 8.9 | 1 | 2.2 | 1 | 2.2 | 0 | 0 |
| Anaemia | 11 | 24.4 | 5 | 11.1 | 1 | 2.2 | 0 | 0 |
| Neutropenia | 3 | 6,7 | 6 | 13.3 | 1 | 2.2 | 0 | 0 |
| Thrombocytopenia | 7 | 15.5 | 5 | 11.1 | 0 | 0 | 0 | 0 |
| Neurotoxicity | 22 | 48.8 | 12 | 26.6 | 1 | 2.2 | 0 | 0 |